ライフサイエンスコーパス: surgical resection

1 of margin status in risk of recurrence after surgical resection.

2 ond favorably to neoadjuvant therapy undergo surgical resection.

3 c therapy alone and 43.8% (10,510) underwent surgical resection.

4 ongoing serum miRNA expression changes after surgical resection.

5 n localized biliary tract cancer (BTC) after surgical resection.

6 ing survival of patients with HCC treated by surgical resection.

7 ded chemotherapy, radiation or ablation, and surgical resection.

8 There were 659 patients (1.9%) underwent surgical resection.

9 was performed preoperatively and during the surgical resection.

10 ctory to systemic therapy and ineligible for surgical resection.

11 ho receive chemotherapy first and proceed to surgical resection.

12 ue in the preoperative clinic and throughout surgical resection.

13 ally involves trans-arterial embolization or surgical resection.

14 d most from the HP, especially subjects with surgical resection.

15 r expansion, and on liver regeneration after surgical resection.

16 fuse growth pattern, which prevents complete surgical resection.

17 DAC progression and metastatic relapse after surgical resection.

18 enrolled less than 10 patients, or included surgical resection.

19 e tumor-free survival of patients undergoing surgical resection.

20 hed germline DNA from 27 patients undergoing surgical resection.

21 obtained from each of these sites during the surgical resection.

22 ted with higher morbidity and more difficult surgical resection.

23 iotherapy, stereotactic radiosurgery, and/or surgical resection.

24 with advanced imaging, possibly followed by surgical resection.

25 tidisciplinary cancer conference recommended surgical resection.

26 r RCT did not increase the rate of pCR after surgical resection.

27 ly of a selective tumor-specific approach to surgical resection.

28 (BOLD) change in the TL overlapping with the surgical resection.

29 predictor of DFS and OS in PHC patients with surgical resection.

30 es are designed to prevent recurrences after surgical resection.

31 y of Anesthesiology score, and the extent of surgical resection.

32 /or endoscopic relapse of CD in adults after surgical resection.

33 on of local lung cancer recurrence following surgical resection.

34 itaxel given as neoadjuvant treatment before surgical resection.

35 recurred triple negative breast tumors after surgical resection.

36 further cycles, which were then followed by surgical resection.

37 lymph node yields (LNY) compared to initial surgical resection.

38 4% rectal P< 0.001) when compared to initial surgical resection.

39 rly local and distant metastasis, even after surgical resection.

40 acy in GIST-bearing xenograft mice following surgical resection.

41 e increasingly being treated with NAT before surgical resection.

42 No patients needed surgical resection.

43 ated toxic effects, which did not compromise surgical resection.

44 ta regarding their long-term follow-up after surgical resection.

45 ed stage and only a minority is eligible for surgical resection.

46 he parenchymal margin) with recurrence after surgical resection.

47 a mixture of treatment regimens with/without surgical resection.

48 mimic the mechanics of tumour growth and of surgical resection.

49 especially in cases that are not amenable to surgical resection.

50 or IIIA disease who have undergone complete surgical resections.

51 serve as a screening tool and help to guide surgical resections.

52 hile 21 (24.7%) patients underwent immediate surgical resection, 64 (75.3%) were initially managed co

53 lostomy-free survival than did those who had surgical resection (74% [95% CI 64-82] vs 47% [37-57]; h

54 rvival were noted between watch and wait and surgical resection (88% [95% CI 75-94] with watch and wa

55 ts with early HCC who are not candidates for surgical resection, ablation and liver transplantation s

56 atment of hepatobiliary malignancies include surgical resection, ablation, and liver transplantation.

57 or more days) from the completion of CRT to surgical resection, adjusted for clinical stage, demogra

58 common childhood liver cancer is cured with surgical resection after chemotherapy or with liver tran

59 underwent radiotherapy or chemoradiotherapy, surgical resection after FOLFIRINOX, and R0 resection.

60 eatic cancer (LAPC) and assess the effect of surgical resection after neoadjuvant therapy on patient

61 operative approaches in terms of quality of surgical resection aimed to demonstrate if one approach

62 esistant epilepsy syndrome of early life.(1) Surgical resection allows limited access to the small de

63 Patients with pT1-2N0M0 SCLC treated with surgical resection alone have worse outcomes than those

64 e to local recurrence compared with that for surgical resection alone.

65 s with LPHL may be spared chemotherapy after surgical resection alone.

66 ocalization and video-assisted thoracoscopic surgical resection alter clinical management and were as

67 ow-up may be improved in patients undergoing surgical resection, although this difference did not mee

68 For patients with incomplete surgical resection, an additional boost of 14.4 Gy was d

69 rapies for malignant brain tumors consist of surgical resection and adjuvant chemoradiation; such app

70 Treatment for glioblastoma (GBM) includes surgical resection and adjuvant radiotherapy (RT) and ch

71 C) is a highly malignant disease, where even surgical resection and aggressive chemotherapy produce d

72 rosis, and improves organ function following surgical resection and chemical injuries.

73 central analysis, and had undergone maximal surgical resection and completion of standard chemoradia

74 newly diagnosed with glioblastoma following surgical resection and conventional radiotherapy in a ph

75 e obtained from 50 patients with PDAC before surgical resection and filtered using the Isolation by S

76 ion of epithelial ovarian cancer (EOC) after surgical resection and first-line chemotherapy, about 60

77 that encompass both benign tumors cured with surgical resection and highly lethal cancers with no eff

78 int is critical for improving the success of surgical resection and increasing 5-year survival rates.

79 ellular carcinoma (HCC) are not eligible for surgical resection and instead undergo local-regional tr

80 eive potentially curative therapies, such as surgical resection and liver transplantation.

81 d neck squamous cell carcinoma who underwent surgical resection and neck dissection with a PN0 neck a

82 as in seven NF2 patients that concluded with surgical resection and performed whole-exome sequencing

83 Local therapy with surgical resection and perhaps radiation therapy is used

84 Patients who underwent surgical resection and postoperative systemic chemothera

85 plications for individualizing the extent of surgical resection and radiation therapy volumes.

86 PDAC patients who undergo surgical resection and receive effective chemotherapy ha

87 system also prevents tumor recurrence after surgical resection and results in 100% metastasis-free s

88 that fails to stop liver regeneration after surgical resections and elucidate mechanisms that are in

89 in vivo tissue assessment tool to help guide surgical resections and streamline surgical workflows.

90 4, who underwent neoadjuvant chemoradiation, surgical resection, and adjuvant therapy.

91 rogeneity, monitor treatment response, focus surgical resection, and enable image-guided biopsy.

92 Patients underwent surgical resection, and tumor samples underwent immunohi

93 by treatment with anticonvulsant medication, surgical resection, and/or nerve/brain electrode stimula

94 cated and remained viable in CrF in CD ileal surgical resections, and identified Clostridium innocuum

95 lanted with intracranial electrodes prior to surgical resection; and (iii) sharing all neuroimaging,

96 For OCSCC, 85% of the surgical resections appear inadequate.

97 negative Hopkins score both in those who had surgical resection as part of the primary treatment (HR

98 uspicion and should be managed with complete surgical resection, as conservative techniques are assoc

99 evice demonstrated robust potential to guide surgical resections, as all peak tumor-to-background rat

100 atment should be initiated within 8 weeks of surgical resection, assuming complete recovery.

101 ergo organ preservation and avoid definitive surgical resection at 5years (67% vs 30%; P = 0.001).

102 cancer centre cohort, 228 of whom underwent surgical resection at referring hospitals and 31 of whom

103 45 Gy preoperative radiotherapy, followed by surgical resection at week 13.

104 , renal oncocytomas, may be overtreated with surgical resection because of limited preoperative diagn

105 ients diagnosed with CRC undergoing elective surgical resection between 2006 and 2013 were included.

106 tudy included patients with HCC treated with surgical resection between January 2008 and February 201

107 toma treatment with curative intent requires surgical resection, but only about a third of newly diag

108 not only improve cancer detection and guide surgical resections, but also improve our understanding

109 Results for 73 biopsies from 10 surgical resection cases show that DESI-MS allows detect

110 development of resistance to therapy (i.e., surgical resection, chemoradiotherapy).

111 Patients were primarily treated with surgical resection, chemotherapy, radiation therapy, or

112 ence of hepatocellular carcinoma (HCC) after surgical resection compromises patient survival.

113 age during follow-up and 11 (17.2%) required surgical resection due to interval bleeding or neurologi

114 Failure to cure was defined as: 1) no surgical resection due to intraoperative metastasis or l

115 Local control consisted of surgical resection during induction chemotherapy and rad

116 rage 12 to 14 months after diagnosis despite surgical resection followed by radiotheraphy and temozol

117 Standard of care consists of surgical resection followed by radiotherapy and concomit

118 f each 21-day cycle, for three cycles before surgical resection, followed by adjuvant intravenous niv

119 rt study included 103 patients who underwent surgical resection for a preoperative diagnosis of MD or

120 irteen individuals with FPC (6.1%) underwent surgical resection for a suspected PRL, but only four (1

121 y squamous cell carcinoma undergoing upfront surgical resection for curative intent were identified i

122 so predicts fewer LNs being identified after surgical resection for EC.

123 Surgical resection for HCC results in good outcomes if p

124 We conclude that the literature on surgical resection for HGGs is influenced by medical aca

125 ectively reviewed 272 patients who underwent surgical resection for histologically confirmed IPMN fro

126 Long-term follow-up data on recurrence after surgical resection for IPMN are currently lacking.

127 The proportion of patients who underwent surgical resection for locally advanced pancreatic cance

128 Two CDKN2A mutation carriers (1%) underwent surgical resection for low-risk PRL.

129 Disparities in the utilization of surgical resection for patients with early-stage, resect

130 s of FOLFOX4 or FOLFOX4 plus cetuximab after surgical resection for stage III colon cancer.

131 cohort study included patients who underwent surgical resection for stage III or IV distal oesophagea

132 tricturing lesions, penetrating lesions, and surgical resection, for measuring disease progression.

133 atients with localized disease who underwent surgical resection formed the study population, and thei

134 cancer specimens from patients who underwent surgical resection from 2002 through 2008.

135 d HCC samples from 59 patients who underwent surgical resection from November 2013 through May 2017,

136 Patients who underwent surgical resection had significant higher median OS comp

137 Surgical resection has a potential benefit for patients

138 th adjuvant chemo- or radiotherapy following surgical resection has been proposed as a potentially ef

139 Although surgical resection has been the primary treatment modali

140 wnstream of Wnt/beta-catenin signaling after surgical resection; however, these drugs have yet to be

141 ve a complete clinical response were offered surgical resection if eligible.

142 cycles of neoadjuvant FLOT and proceeded to surgical resection if restaging (using computed tomograp

143 present analysis, we examine whether upfront surgical resection improves overall survival in a large

144 lete removal of residual tumor tissue during surgical resection improves patient outcomes.

145 survival at 3, 5, and 10 years after initial surgical resection in a tertiary centre.

146 lmFG activity through stimulation, and later surgical resection in one of the patients, led to impair

147 outcome to perioperative cancer therapy and surgical resection in patients with gastric cancer.

148 ges were supported for the use of endoscopic surgical resection in patients with limited disease (T1,

149 data on all patients with T1 CRC undergoing surgical resection in Sweden, 2009-2017 and Denmark 2016

150 t and to identify predictors of the need for surgical resection in the subgroup of patients with stra

151 Surgical resection including regions of haemodynamic cha

152 ssary, the standard treatment is gross total surgical resection including the involved dura.

153 For patients with liver cancer, surgical resection is a principal treatment modality tha

154 Aggressive surgical resection is a successful approach in some pati

155 Similarly, surgical resection is also the definitive treatment for

156 Although surgical resection is associated with a complete cure in

157 of 85 to 98 days between CRT completion and surgical resection is associated with significantly incr

158 Surgical resection is mandatory to prevent threatening m

159 nded that a comparison between ESD and local surgical resection is needed to guide decision making fo

160 Elective surgical resection is no longer recommended solely based

161 nd within 3 months for high-risk lesions, if surgical resection is not planned.

162 ductal adenocarcinoma (PDAC) after complete surgical resection is often followed by distant metastat

163 impossible for a stage to be assigned until surgical resection is performed.

164 Primary surgical resection is recommended for all patients who h

165 However, surgical resection is recommended for patients with an M

166 Surgical resection is regarded as the only potentially c

167 Surgical resection is standard treatment for patients wi

168 Currently, surgical resection is the most effective way to manage s

169 Surgical resection is the only curative treatment for pa

170 Surgical resection is the primary and most effective tre

171 Surgical resection is the standard of care for MPNSTs, b

172 ladder cancer and a microscopically positive surgical resection margin (R1 resection) may be offered

173 biopsied samples of the oral tumour and the surgical resection margin with more than 95% sensitivity

174 c tissue sections and prospectively evaluate surgical resection margins from pancreatic cancer surger

175 Although surgical resection may be required, disease frequently r

176 sequenced primary tumour types obtained from surgical resections, much less comprehensive molecular a

177 esistant tuberculosis undergoing therapeutic surgical resection (n = 14) and healthy lung tissue from

178 6) and was limited to patients who underwent surgical resection (n = 47,302 excluded).

179 tive CECTs of 157 HCC patients who underwent surgical resection (N = 72) or LT (N = 85) between 2000

180 with a complete radiological response after surgical resection (n=900) or local ablation (n=214) in

181 invasive carcinoma can occur years after the surgical resection of a non-invasive IPMN.

182 Complete surgical resection of abnormal brain tissue is the most

183 Nomograms to predict RFS and OS after surgical resection of ACC were proposed using a multi-in

184 Patients who underwent surgical resection of appendiceal NETs at 11 tertiary It

185 ave influenced strategies and thresholds for surgical resection of BAV aortopathy.

186 heir potential clinical use as an adjunct to surgical resection of cancers.

187 -detected pulmonary venous CTCs (PV-CTCs) at surgical resection of early-stage NSCLC represent subclo

188 A total of 804 patients who underwent surgical resection of gastric adenocarcinoma were identi

189 (33 female) who had undergone endoscopic or surgical resection of GHPs.

190 The risk of recurrence following surgical resection of GISTs is typically reported from t

191 ed protoporphyrin IX (PpIX) for image-guided surgical resection of high-grade brain tumors (glioblast

192 Five patients awaiting surgical resection of histologically proven or radiologi

193 Surgical resection of LAPC after neoadjuvant therapy is

194 improve the survival rate of patients after surgical resection of large amounts of liver tissue.

195 These preliminary analyses suggest that surgical resection of liver metastases should be careful

196 Patients with incomplete surgical resection of medulloblastoma are controversiall

197 aluate the survival benefit achieved through surgical resection of melanoma metastatic to the abdomin

198 Of 201 patients managed without surgical resection of metastases, 83 (41%), 89 (44%), an

199 ne green) for aiding the fluorescence-guided surgical resection of primary and metastatic liver tumou

200 Following the surgical resection of primary EMT6 tumors, mice do not d

201 val and negative margins are the goal of any surgical resection of primary oral cavity carcinoma.

202 te remaining tumor tissues are needed during surgical resection of prostate adenocarcinoma.

203 r marker levels, radiology, and pathology at surgical resection of residual disease.

204 val and distant metastases in patients after surgical resection of soft-tissue sarcoma of the extremi

205 Metastasis can occur following surgical resection of solid tumors and metastasis is the

206 ith pharmacoresistant focal epilepsy in whom surgical resection of the epileptogenic focus fails or w

207 al thinning in these areas was reduced after surgical resection of the left (0.0074 +/- 0.0016 mm/yea

208 A highly invasive surgical resection of the liver tumor is the main approa

209 es after resection of the primary tumor, and surgical resection of the metastases offers the only opp

210 Surgical resection of the most destroyed sections of the

211 IVE) could not demonstrate an OS benefit for surgical resection of the primary in breast cancer patie

212 cting evidence exists regarding the value of surgical resection of the primary in stage IV breast can

213 st cancer patients were randomly assigned to surgical resection of the primary tumor followed by syst

214 Complete surgical resection of the primary tumor is an important

215 Surgical resection of the primary tumor occurs in almost

216 Surgical resection of the primary tumor remains controve

217 Patients underwent surgical resection of the target lesions, and tissues we

218 not eligible for curative therapies, such as surgical resection of the tumor or a liver transplant.

219 mpetent hosts improved animal survival after surgical resection of the tumors, by suppression of tumo

220 tion, management strategies, which encompass surgical resection of the tumour, cranio-spinal irradiat

221 TNM staging system and is the rationale for surgical resection of tumor-draining lymph nodes.

222 hods Patients with VHL disease who underwent surgical resection of tumors between November 2014 and O

223 CTCs in pulmonary vein blood accessed during surgical resection of tumors.

224 Surgical resection of tumours requires precisely locatin

225 Surgical resections of CRC LM were identified from hospi

226 HGD of the esophagus may be managed by surgical resection or EMR-RFA.

227 of the liver is essential for recovery from surgical resection or injuries induced by trauma or toxi

228 ent predictor of poor outcomes subsequent to surgical resection or liver transplantation (LT); howeve

229 patients with hepatocellular carcinoma after surgical resection or local ablation.

230 giocarcinoma (Klatskin tumors) is limited to surgical resection or orthotopic liver transplantation.

231 nts with localized disease can be cured with surgical resection or radiotherapy, but such curative op

232 atients with brain metastases unsuitable for surgical resection or stereotactic radiotherapy were ran

233 tients (tumor and paired normal tissues from surgical resections) or biofilm-positive biopsies from h

234 ors, including age, tumor location, M stage, surgical resection, order of therapy, germline status, a

235 ith the intracranial EEG (iEEG) findings and surgical resection outcomes in a cohort of 36 patients w

236 tal cancer in terms of individual quality of surgical resection outcomes.

237 s were obtained from an endoscopic biopsy or surgical resections performed at Johns Hopkins Hospital.

238 ship between tumor and the low rectal cancer surgical resection plane (mrLRP).

239 The surgical resection procedures such as the radical pancre

240 Surgical resection provides better long-term OS and RFS

241 dismal prognosis, despite best treatment by surgical resection, radiation therapy (RT) and chemother

242 median survival of less than 2 years despite surgical resection, radiation, and chemotherapy.

243 brain tumor in children, remains limited to surgical resection, radiation, and traditional chemother

244 ors associated with long-term outcomes after surgical resection remain poorly defined.

245 Cancer recurrence after surgical resection remains a significant cause of treatm

246 inal melanoma metastases, demonstrating that surgical resection remains an important treatment consid

247 Surgical resection remains the cornerstone of management

248 Surgical resection remains the cornerstone of therapy fo

249 Although surgical resection remains the primary treatment modalit

250 r surgery prediction by performing in silico surgical resections, removing nodes from patient network

251 Surgical resection represents the only chance for cure,

252 Surgical resection resulted in a significant 36.2% reduc

253 treatment in some sub-types warrants radical surgical resections resulting in high morbidity.

254 Surgical resection should be considered as the first-lin

255 BEST PRACTICE ADVICE 11: Surgical resection should be performed at high-volume ce

256 Although maximum safe surgical resection should remain the standard of care, s

257 Brain tissue surrounding surgical resection site can be injured inadvertently due

258 istologic patterns of lung adenocarcinoma on surgical resection slides.

259 hich leads to patients undergoing aggressive surgical resections, so-called second-look surgeries, an

260 uorescence-guided imaging (FGI) of the fresh surgical resection specimens (n = 8) was performed.

261 Intestinal crypts were obtained from surgical resection specimens of 7 individuals without in

262 clinical complete response and those who had surgical resection (standard care).

263 from melanoma is controversial and includes surgical resection, stereotactic radiosurgery (SRS), and

264 consensus about their management is lacking, surgical resection still plays a role.

265 After surgical resection, strain of full gut wall segments was

266 ough bottlenecks, but re-grow by the time of surgical resection, suggesting a missed therapeutic oppo

267 proliferation positive because both require surgical resection, the sensitivity increased to 97.5% a

268 -94] with watch and wait vs 78% [63-87] with surgical resection; time-varying p=0.043).

269 Archival surgical resection tissue contained RNA foci, dipeptide

270 ith BE who have dysplasia or early EAC, from surgical resection to endoscopic resection and ablation.

271 a tool for evaluating the CRM directly after surgical resection to improve tumor-negative CRM rates.

272 merically investigate different protocols of surgical resection using our model and provide possible

273 -one paired cohorts of watch and wait versus surgical resection using propensity-score matching (incl

274 HPV-negative OPSCC when treated with primary surgical resection vs CRT.

275 Primary surgical resection vs definitive CRT.

276 The mean duration of epilepsy before surgical resection was 20.1 years among adults and 5.3 y

277 Mean follow-up from surgical resection was 32 +/- 8 months.

278 ic survival among the patients who underwent surgical resection was independently associated with geo

279 The extent of surgical resection was influenced by synchronous colonic

280 Surgical resection was performed in 85% and radiation in

281 herapy-naive NSCLC patients for whom primary surgical resection was planned.

282 Surgical resection was significantly associated with bet

283 Complete surgical resection was subsequently performed and histop

284 Only patients who underwent surgical resection were considered (n = 170).

285 d clinical data on neoadjuvant treatment and surgical resection were documented.

286 ed neoadjuvant chemoradiotherapy followed by surgical resection were included.

287 or and tumor bed from 50 patients undergoing surgical resections were subject to DESI MSI.

288 ated colonic diverticulitis usually requires surgical resection, which is associated with significant

289 c agents to the glioma cells remaining after surgical resection while sparing normal healthy brain ce

290 Only 20% of patients are eligible for surgical resection with curative intent, with 5-year ove

291 ystematic review and meta-analysis comparing surgical resection with endovascular treatment in terms

292 Surgical resection with microscopically negative margins

293 ding squamous cell carcinoma (SCC), involves surgical resection with negative cancer margins.

294 For many tumors, primary treatment is surgical resection with negative margins, which correspo

295 hn disease who had strictures that underwent surgical resection with pathologic confirmation.

296 rrelated the network damage score (caused by surgical resection) with postsurgical brain function, an

297 f oncological factors indicating an adequate surgical resection, with a noninferiority boundary of De

298 with nonmetastatic breast cancer consists of surgical resection, with consideration of postoperative

299 andardized 3-drug preoperative chemotherapy, surgical resection within 12 weeks of diagnosis and resp

300 dern systemic therapy and undergo successful surgical resection without prohibitive perioperative com